India Drug Makers Among First Cleared By U.S. To Sell Acid-Reflux Generic
This article was originally published in PharmAsia News
Executive Summary
Three India drug makers, Dr. Reddy's Laboratories, Lupin and Torrent Pharma, are among six to be cleared by U.S. FDA to market the first generic versions of Eisai's Aciphex (rabeprazole) acid-reflux drug.